Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eton Pharmaceuticals Inc.

    NASDAQ: ETON · Real-Time Price · USD
    14.30
    -0.21 (-1.45%)
    At close: Jun 13, 2025, 3:59 PM
    14.48
    1.25%
    After-hours: Jun 13, 2025, 05:54 PM EDT

    Eton Pharmaceuticals Statistics

    Share Statistics

    Eton Pharmaceuticals has 26.82M shares outstanding. The number of shares has increased by 4.39% in one year.

    Shares Outstanding

    n/a
    		 26.82M

    Shares Change (YoY)

    n/a
    		 4.39%

    Shares Change (QoQ)

    n/a
    		 0.69%

    Owned by Institutions (%)

    n/a
    		 50.72%

    Shares Floating

    n/a
    		 23.5M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,249

    FTD / Avg. Volume

    n/a
    		 1.04%

    Short Selling Information

    The latest short interest is 823.78K, so 3.07% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 823.78K

    Short % of Shares Out

    n/a
    		 3.07%

    Short % of Float

    n/a
    		 3.23%

    Short Ratio (days to cover)

    n/a
    		 2.05

    Valuation Ratios

    The PE ratio is -90.22 and the forward PE ratio is 11.8. Eton Pharmaceuticals's PEG ratio is -0.29.

    PE Ratio

    n/a
    		 -90.22

    Forward PE

    n/a
    		 11.8

    PS Ratio

    n/a
    		 8.84

    Forward PS

    n/a
    		 1.7

    PB Ratio

    n/a
    		 14.12

    P/FCF Ratio

    n/a
    		 365.77

    PEG Ratio

    n/a
    		 -0.29
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Eton Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.22.

    Current Ratio

    n/a
    		 2.06

    Quick Ratio

    n/a
    		 1.29

    Debt / Equity

    n/a
    		 1.22

    Debt / EBITDA

    n/a
    		 -20.62

    Debt / FCF

    n/a
    		 31.73

    Interest Coverage

    n/a
    		 -1.3

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,258,419.35

    Profits Per Employee

    n/a
    		 $-123,322.58

    Employee Count

    n/a
    		 31

    Asset Turnover

    n/a
    		 0.51

    Inventory Turnover

    n/a
    		 1.02

    Taxes

    Income Tax

    n/a
    		 15K

    Effective Tax Rate

    n/a
    		 -0.39%

    Stock Price Statistics

    The stock price has increased by 300.28% in the last 52 weeks. The beta is 1.28, so Eton Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.28

    52-Week Price Change

    n/a
    		 300.28%

    50-Day Moving Average

    n/a
    		 16.3

    200-Day Moving Average

    n/a
    		 12.56

    Relative Strength Index (RSI)

    n/a
    		 29.91

    Average Volume (20 Days)

    n/a
    		 313,131

    Income Statement

    In the last 12 months, Eton Pharmaceuticals had revenue of 39.01M and earned -3.82M in profits. Earnings per share was -0.15.

    Revenue

    n/a
    		 39.01M

    Gross Profit

    n/a
    		 23.41M

    Operating Income

    n/a
    		 -2.6M

    Net Income

    n/a
    		 -3.82M

    EBITDA

    n/a
    		 -1.45M

    EBIT

    n/a
    		 -2.6M

    Earnings Per Share (EPS)

    n/a
    		 -0.15
    Full Income Statement

    Balance Sheet

    The company has 14.94M in cash and 29.92M in debt, giving a net cash position of -14.98M.

    Cash & Cash Equivalents

    n/a
    		 14.94M

    Total Debt

    n/a
    		 29.92M

    Net Cash

    n/a
    		 -14.98M

    Retained Earnings

    n/a
    		 -107.89M

    Total Assets

    n/a
    		 84.03M

    Working Capital

    n/a
    		 24.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 969K and capital expenditures -26K, giving a free cash flow of 943K.

    Operating Cash Flow

    n/a
    		 969K

    Capital Expenditures

    n/a
    		 -26K

    Free Cash Flow

    n/a
    		 943K

    FCF Per Share

    n/a
    		 0.04
    Full Cash Flow Statement

    Margins

    Gross margin is 60.01%, with operating and profit margins of -6.66% and -9.8%.

    Gross Margin

    n/a
    		 60.01%

    Operating Margin

    n/a
    		 -6.66%

    Pretax Margin

    n/a
    		 -9.76%

    Profit Margin

    n/a
    		 -9.8%

    EBITDA Margin

    n/a
    		 -3.72%

    EBIT Margin

    n/a
    		 -6.66%

    FCF Margin

    n/a
    		 2.42%

    Dividends & Yields

    ETON does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ETON is $28, which is 92.7% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $28

    Price Target Difference

    n/a
    		 92.7%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 4.44

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist